2025-07-25 - Analysis Report
Okay, here's a report summarizing the analysis of Intuitive Surgical Inc. (ISRG), designed to be easily digestible with key numbers upfront.

**Report: Intuitive Surgical Inc. (ISRG) Analysis**

**1. Performance Overview:**

*   **Ticker:** ISRG
*   **Company Description:** Intuitive Surgical Inc. develops, manufactures, and markets robotic surgical systems.

**Key Performance Numbers:**

*   **ISRG Total Return:** 114.73%
*   **S&P 500 (VOO) Total Return:** 98.88%
*   **Return Spread (ISRG - VOO):** 20.5
*   **Relative Spread Percentile:** 20.3%
*   **Last Price:** $488.61

**Return Spread Analysis:**

ISRG has outperformed the S&P 500 (VOO) with a current spread of 20.5%. The Relative Spread Percentile of 20.3% suggests that ISRG's outperformance is currently positioned in the lower range of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 39.0% | 0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 59.0% | 0.0 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 28.0% | 0.2 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 43.0% | 0.2 | 128.8 |
| 2020-2022  | -3.0% | 69.9% | -6.0% | 0.2 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -23.0% | 0.9 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 0.0% | 0.9 | 187.1 |
| 2023-2025  | 35.0% | 72.9% | -15.0% | 0.7 | 175.1 |

**Analysis:**

*   **CAGR:** ISRG's Compounded Annual Growth Rate (CAGR) has fluctuated significantly over the years, with high growth periods followed by declines. The most recent periods (2020-2025) show varying performance.
*   **MDD:** The Maximum Drawdown (MDD) indicates the maximum loss from peak to trough during the period. Consistently high MDD values suggest significant volatility.
*   **Alpha:** Alpha measures the excess return compared to the benchmark (S&P 500). ISRG has periods of strong positive alpha, indicating significant outperformance, as well as periods of negative alpha, suggesting underperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market. Beta values generally around 0.2 to 0.9 indicate that ISRG is less volatile than the market.
*   **Cap(B):** Market capitalization (in billions) has shown significant growth over the periods, reflecting ISRG's expansion and investor confidence, despite volatility in returns.

**2. Recent Price Action:**

*   **Current Price:** $488.61
*   **Previous Close:** $501.95
*   **Price Change:** -2.66%
*   **5-Day Moving Average:** $507.26
*   **20-Day Moving Average:** $523.05
*   **60-Day Moving Average:** $532.95

**Analysis:** The recent price decline, falling below the 5-day, 20-day, and 60-day moving averages, indicates short-term downward momentum. The significant price change from the previous close suggests notable selling pressure.

**3. Technical Indicators & Return Expectation:**

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 14.67 (Oversold)
*   **PPO:** -0.55
*   **Hybrid Signal:** cash_69%_Sell 69.7% of holdings (380 shares - Caution - MRI:0.35) (Cash Ratio: 69% on 2025-07-15)
*   **Change in Relative Spread (20-Day):** -1.7 (Short-term Decrease)
*   **Expected Return:** 164.6%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment.
*   **RSI:** The low RSI value indicates that the stock is currently oversold, which could present a potential buying opportunity for investors expecting a rebound.
*   **PPO:** The negative PPO value implies that the short-term moving average is below the long-term moving average, indicating a downtrend.
*   **Hybrid Signal:** The hybrid signal indicates a recommendation to sell a significant portion of holdings and increase cash reserves due to caution indicated by the MRI.
*   **Price Change Impact:** Given the substantial price change, the Hybrid Signal appears to be factoring in recent volatility and potential further downside.
*   **Expected Return:** The high expected return suggests significant long-term growth potential from the current price levels.

**4. Recent News & Significant Events:**

*   **2025-07-25:** ISRG has recently made headlines due to major business developments, regulatory changes, or market events.
*   **2025-07-21:** Analysts are discussing ISRG's recent performance and its outlook in the context of industry trends and global economic factors.
*   **2025-07-22:** ISRG's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-23:** Market experts highlight both risks and opportunities for ISRG, advising investors to monitor recent news and company announcements.

**Analysis:** Recent news indicates significant activity and discussion surrounding ISRG, with a focus on volatility, performance, and potential risks and opportunities. This underscores the importance of staying informed about company announcements and market developments.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2025-07-23 | 1.48 | 2.01 B$   |

**Analysis:**

*   **EPS:** The Earnings Per Share (EPS) has shown fluctuations. Recent EPS is higher than in previous periods.
*   **Revenue:** Revenue has generally been increasing over the observed periods.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $2.25B   | 64.69%        |
| 2024-12-31   | $2.41B   | 68.04%        |
| 2024-09-30   | $2.04B   | 67.41%        |
| 2024-06-30   | $2.01B   | 68.30%        |
| 2024-03-31   | $1.89B   | 65.87%        |

**Analysis:**

*   **Revenue:** Revenue has been growing steadily, indicating strong sales performance.
*   **Profit Margin:** Profit margins remain consistently high, suggesting efficient cost management and pricing strategies.

**Capital and Profitability:**

| Quarter      | Equity   | ROE     |
|--------------|----------|---------|
| 2025-03-31   | $17.11B  | 4.08%   |
| 2024-12-31   | $16.43B  | 4.17%   |
| 2024-09-30   | $15.58B  | 3.63%   |
| 2024-06-30   | $14.71B  | 3.58%   |
| 2024-03-31   | $13.96B  | 3.90%   |

**Analysis:**

*   **Equity:** Equity has been consistently increasing, indicating a strengthening financial position.
*   **ROE:** The Return on Equity (ROE) remains relatively stable, reflecting consistent profitability and efficient use of shareholder equity.

**7. Overall Summary & Conclusion:**

Intuitive Surgical Inc. (ISRG) is a company with strong long-term growth potential, as indicated by its high expected return and increasing revenue and equity. However, recent performance indicates some short-term challenges. Here's a breakdown:

*   **Strengths:**
    *   Strong long-term outperformance relative to the S&P 500.
    *   High expected return for long-term investors.
    *   Consistent revenue growth and high profit margins.
    *   Increasing equity and stable ROE.
*   **Weaknesses/Concerns:**
    *   Recent price decline and negative short-term technical indicators (RSI in oversold territory).
    *   Hybrid Signal suggests selling a significant portion of holdings.
    *   Volatility and sensitivity to market events and news.
*   **Recent Volatility:** The price drop below key moving averages and negative price change warrants caution.
*   **Recommendation:** Given the conflicting signals (oversold RSI vs. Sell Hybrid Signal), a prudent approach would be to monitor the stock closely for a reversal in trend. Long-term investors might consider dollar-cost averaging if confident in the company's fundamentals, while short-term traders should be wary of continued downward pressure. Staying informed about company news and analyst opinions is crucial.

In conclusion, ISRG presents a mixed picture. While its long-term prospects appear promising, recent developments suggest caution and the need for careful monitoring.

